InceptionR’s Kura Oncology KURA Stock Holding History

InceptionR’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,823	Closed	-$202K	–	791
2026 Q1	$202K	Buy	+24,823	New	+$213K	0.05%	589

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

InceptionR's KURA Position: Q2 2026 in Review

InceptionR sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 24,823 shares — an estimated $202K sold.

InceptionR first reported a position in KURA in Q1 2026 and held it in 1 quarter. The position peaked at $202K in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

InceptionR reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
InceptionR sold 24,823 Kura Oncology shares in Q2 2026, an estimated $202K.
InceptionR first reported a position in Kura Oncology in Q1 2026 and held it in 1 quarter.
InceptionR's Kura Oncology position peaked at $202K in Q1 2026.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.